
Gestra 2mg/0.035mg Tablet
Marketer
Gynogen
Salt Composition
Cyproterone (2mg) + Ethinyl Estradiol (0.035mg)
Overview Gestra 2mg/0.035mg Tablet
Combifem 2mg/0.035mg tablets combine two hormones to alleviate polycystic ovary syndrome (PCOS) symptoms like unwanted hair growth, acne, and menstrual irregularities. It also functions as birth control; therefore, avoid concurrent use of other contraceptives. This medication may be taken with or without food, consistently at the same time daily for improved adherence. Dosage and treatment length vary based on your condition; however, always complete the prescribed course. Typical side effects include nausea, abdominal discomfort, headache, weight increase, and breast tenderness. Report any concerning or persistent side effects to your physician; management options may be available. Consult your doctor if you experience mid-cycle spotting or brown discharge. Seek immediate medical attention for unexplained limb swelling and pain, breathlessness, chest pain, or vision disturbances. Discontinue use and contact your physician if menstruation doesn't begin within one week of treatment. Inform your doctor about all other medications you're using, as interactions may reduce efficacy or alter the drug's effects. Do not use this medication if pregnant or breastfeeding.
Uses of Gestra 2mg/0.035mg Tablet
Managing Polycystic Ovary Syndrome (PCOS)
Major Benefits of Gestra 2mg/0.035mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2mg/0.035mg Gestra tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended.
Common Side effects of Gestra 2mg/0.035mg Tablet:
- Nausea
- Stomach pain
- Headache
- Weight gain
- Breast pain
- Mood changes
How to use Gestra 2mg/0.035mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2mg/0.035mg Gestra tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended.
How Gestra 2mg/0.035mg Tablet works:
Gestra 2mg/0.035mg tablets contain Cyproterone and Ethinyl Estradiol, two hormones that effectively manage Polycystic Ovary Syndrome (PCOS) symptoms. These include acne, excessive body hair (hirsutism), and menstrual irregularities. Cyproterone's mechanism involves suppressing excess androgen (male hormone) production within the ovaries, mitigating acne and hirsutism. Ethinyl Estradiol complements this action by lowering circulating androgen levels. This combined effect also leads to the normalization of menstrual cycles in women with PCOS.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Gestra 2mg/0.035mg Tablets requires careful consideration. Physician consultation is recommended.
PregnancyUNSAFE
The use of Gestra 2mg/0.035mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in both animal and human studies has revealed substantial adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
The use of Gestra 2mg/0.035mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Gestra 2mg/0.035mg Tablets.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Gestra 2mg/0.035mg tablets to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Data regarding Gestra 2mg/0.035mg Tablet use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Gestra 2mg/0.035mg Tablet :
Should you forget a Gestra 2mg/0.035mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gestra 2mg/0.035mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
